Sugi Predict

Sugi Predict / Compounds / SCHEMBL12247698

SCHEMBL12247698

SCHEMBL12247698

CS(=O)(=O)N[C@H](CCc1ccccc1)C(=O)N1C[C@H](OCc2ccc(Cl)cc2)C[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)c1nc2ccccc2s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRSS1 P07477 5/20 0.41
▸ TPSAB1 Q15661 2/20 0.41
▸ F2 P00734 13/20 0.41
▸ PRKD3 O94806 2/20 0.38
▸ F10 P00742 2/20 0.38
▸ PLAU P00749 2/20 0.38
▸ PLAT P00750 2/20 0.38
▸ PRKCG P05129 2/20 0.38
▸ PRKCB P05771 2/20 0.38
▸ F7 P08709 2/20 0.38
▸ PRKCA P17252 2/20 0.38
▸ PRKCH P24723 2/20 0.38
▸ PRKCI P41743 2/20 0.38
▸ PRKCE Q02156 2/20 0.38
▸ PRKCQ Q04759 2/20 0.38
▸ PRKCZ Q05513 2/20 0.38
▸ PRKCD Q05655 2/20 0.38
▸ PRKD1 Q15139 2/20 0.38
▸ PRSS2 P07478 1/20 0.38
▸ PRSS3 P35030 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8225420 0.94 PRSS1 (0.42) PRSS1TPSAB1F2PRKD3F10
SCHEMBL8225219 0.91 PRSS8 (0.42) PRSS1TPSAB1F2PRKD3F10
SCHEMBL12247750 0.91 MC4R (0.41) PRSS1TPSAB1F2PRKD3F10
SCHEMBL8233688 0.89 PRSS8 (0.47) —
SCHEMBL12637055 0.88 PRSS1 (0.44) PRSS1TPSAB1F2PRKD3F10
SCHEMBL12247700 0.87 PRSS8 (0.43) PRSS1TPSAB1F2PRKD3F10
SCHEMBL12514708 0.83 PRSS1 (0.46) PRSS1TPSAB1F2PRKD3F10
SCHEMBL12247718 0.83 HDAC3 (0.41) PRSS1TPSAB1F2PRKD3F10
SCHEMBL8175756 0.82 PRSS8 (0.37) F2
SCHEMBL8233684 0.81 PRSS8 (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8338469-B2 Compounds and compositions as channel activating protease inhibitors IRM LLC (BM) 2012-12-25 — — US disclosed
US-20110257077-A1 COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS IRM LLC (BM) 2011-10-20 — — US disclosed
US-7951823-B2 Compounds and compositions as channel activating protease inhibitors IRM LLC (BM) 2011-05-31 — — US disclosed
US-7951823-B2 Compounds and compositions as channel activating protease inhibitors IRM LLC (BM) 2011-05-31 — — US disclosed
US-20070275906-A1 Compounds and Compositions as Channel Activating Protease Inhibitors IRM LLC (BM) 2007-11-29 — — US disclosed
US-20070275906-A1 Compounds and Compositions as Channel Activating Protease Inhibitors IRM LLC (BM) 2007-11-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257077-A1 COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS PRSS1, PRSS8, PRSS2 PRSS1 1/4885TPSAB1 50/4885F2 1402/4885
US-20070275906-A1 Compounds and Compositions as Channel Activating Protease Inhibitors PRSS1, PRSS8, PRSS2 PRSS1 1/4885TPSAB1 50/4885F2 1402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.